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rain-derived neurotrophic factor (BDNF) plays an
important role in synaptic plasticity but the under-
lying signaling mechanisms remain unknown. Here,
we show that BDNF rapidly recruits full-length TrkB (TrkB-FL)
receptor into cholesterol-rich lipid rafts from nonraft regions
of neuronal plasma membranes. Translocation of TrkB-FL
was blocked by Trk inhibitors, suggesting a role of TrkB
tyrosine kinase in the translocation. Disruption of lipid
rafts by depleting cholesterol from cell surface blocked
B
 
the ligand-induced translocation. Moreover, disruption of
lipid rafts prevented potentiating effects of BDNF on trans-
mitter release in cultured neurons and synaptic response
to tetanus in hippocampal slices. In contrast, lipid rafts are
not required for BDNF regulation of neuronal survival.
Thus, ligand-induced TrkB translocation into lipid rafts may
represent a signaling mechanism selective for synaptic
modulation by BDNF in the central nervous system.
 
Introduction
 
In the central nervous system (CNS), brain-derived neuro-
trophic factor (BDNF) not only promotes neuronal survival and
differentiation, but also regulates synaptic transmission and
plasticity. Pharmacological studies demonstrate BDNF en-
hances the survival of cortical neurons in culture (Ghosh et al.,
1994). On the other hand, substantial experiments suggest that
a major function of BDNF in the CNS is to regulate synaptic
transmission and plasticity (Lu, 2003). In cultured hippocampal
or cortical neurons, application of BDNF elicits a rapid potenti-
ation of excitatory synaptic transmission primarily by enhancing
presynaptic transmitter release (Lessmann, 1998; Takei et al.,
1998). In slices, BDNF facilitates hippocampal long-term
potentiation (LTP) and enhances synaptic response to LTP-
inducing tetanus (Figurov et al., 1996; Patterson et al., 1996).
Both in vitro and in vivo studies demonstrate that BDNF in-
duces complex effects on dendritic arborization of pyramidal
neurons (McAllister et al., 1995).
Despite rapid progress in this area, the molecular mecha-
nisms remain ill defined (Lu, 2003). All the functions of
BDNF are mediated by TrkB, a receptor tyrosine kinase
(RTK; Kaplan and Miller, 2000). Binding of BDNF rapidly
activates its tyrosine kinase, which in turn triggers multiple
intracellular signaling pathways. Downstream pathways include
MAPK, phosphatidylinositol 3-kinase (PI3-K) and PLC
 
 
 
. A
critical yet poorly understood issue is how signals from this
receptor are transduced to mediate diverse biological functions
in CNS neurons.
One idea for specific signal-function coupling is that
different signaling pathways may be transduced in different
subcellular compartments. More specifically, it has been pro-
posed that cholesterol/sphingolipid-rich microdomains called
lipid rafts make a specialized signaling platform in the plasma
membrane, and therefore can transduce signals different from
those in the nonraft membrane (Simons and Toomre, 2000;
Anderson and Jacobson, 2002). Because both lipid components
are resistant to solubilization with nonionic detergents, lipid
rafts can be biochemically isolated as detergent-resistant mem-
brane fractions. Raft fractions prepared from brain tissues are
enriched in proteins that carry lipid modifications such as
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glycosylphosphatidylinositol (GPI)-anchored proteins, as well
as palmitylated or myristoylated proteins such as Src-family ki-
nases and trimeric or small G proteins, suggesting a crucial role
of lipid rafts in signal transduction in the CNS (Paratcha and
Ibanez, 2002). Recently, lipid rafts have been shown to serve
as organizing platforms for chemotrophic guidance of nerve
growth cones (Guirland et al., 2004). Transmembrane RTKs,
including EGF receptor (Mineo et al., 1999) and FGF receptor
(Citores et al., 1999) are associated with rafts. The localization
of certain signaling molecules in the rafts allows them to inter-
act with each other more efficiently, and prevents them from
interacting with the proteins outside rafts (Simons and Toomre,
2000). Thus, entering and exiting lipid rafts of RTKs represent
a unique mechanism that transduces differential signals at the
subcellular levels. In the present study, we used brain tissues,
slices and dissociated cultures to examine whether TrkB recep-
tor is localized in lipid rafts of the plasma membrane, and if so,
how the localization is regulated and what the functional roles
are. Our results reveal a BDNF-induced TrkB translocation
into the lipid rafts, and such translocation is important for
BDNF-induced synaptic modulation in CNS neurons.
 
Results
 
BDNF-induced translocation of TrkB into 
lipid rafts
 
Lipid raft fraction was prepared from tissues or primary cul-
tures of cerebral cortex according to the method of Kawabuchi
et al. (2000; Fig. S1A, available at http://www.jcb.org/cgi/
content/full/jcb.200404106/DC1). We first examined whether
full-length TrkB (TrkB-FL) and its ligand BDNF were local-
ized in lipid rafts at different stages of cortical development. Both
proteins exhibit a gradual increase in lipid rafts after birth (Fig. S1
B). The components of the lipid rafts, such as cholesterol and
raft marker proteins caveolin-2 and Fyn, also increased in rafts
during postnatal development (Fig. S1 C), raising the possibil-
ity that the raft localization of TrkB and BDNF may depend on
the developmental expression of these components in rafts. The
parallel increase of TrkB and BDNF in lipid rafts also suggests
that BDNF may regulate the localization of TrkB in lipid rafts.
To directly test whether BDNF recruits TrkB into lipid
rafts, we prepared the rafts in cultured cortical neurons treated
with BDNF. In the cortical cultures used here, 93.3 
 
 
 
 2.4%
and 3.8 
 
 
 
 0.7% are NSE-positive neurons and GFAP-positive
astrocytes, respectively (
 
n 
 
  
 
6 independent experiments). As
shown in Fig. 1 A, application of BDNF induced an increase in
TrkB-FL in the raft fraction. There was a low amount of TrkB-
FL in lipid rafts in naïve neurons, suggesting that in naive cells
TrkB-FL may be associated with rafts with a low affinity. In
cultures stimulated with 200 ng/ml BDNF for 30 min, the
amount of TrkB-FL was markedly increased in rafts (TrkB-
FL
 
BDNF-treated
 
/TrkB-FL
 
control
 
: 3.4 
 
 
 
 0.8-fold, P 
 
 
 
 0.03) but de-
creased slightly in nonrafts (23.1 
 
 
 
 6.4%). Total proteins in
both regions were not changed by the BDNF treatment (Fig. 1
A). When expressed as TrkB-FL/total protein, BDNF increased
TrkB-FL in rafts by 3.63 
 
 
 
 0.73-fold, indicating that BDNF se-
lectively increases the amount of TrkB-FL, but not protein con-
centration, in rafts.
A time course study demonstrated that the partition of
TrkB-FL into rafts was significant at 5 min, peaked at 30–120
min after BDNF application, and returned to control levels
within 6 h (Fig. 1 B). The translocation was observed 1 min
after BDNF addition (Fig. S2, available at http://www.jcb.
org/cgi/content/full/jcb.200404106/DC1). On the other hand,
TrkB-FL in nonraft fraction exhibited a gradual decrease after
BDNF exposure (Fig. 1 B). BDNF-induced recruitment of
TrkB-FL into rafts was dose dependent (Fig. 1 C). To confirm
that BDNF selectively translocated TrkB-FL into lipid rafts, we
examined whether BDNF stimulation also affects the distribu-
tion of other receptors in the rafts and nonraft membrane frac-
Figure 1. BDNF-induced translocation of TrkB-
FL into lipid rafts in cultured cortical neurons.
(A) Effect of BDNF on the distribution of mem-
brane proteins in lipid raft and nonraft frac-
tions. Cultured neurons were treated with or
without 200 ng/ml BDNF for 30 min. An ex-
ample is shown on the left. Note that TrkB-FL,
but not EGFR or TfR, was recruited into fraction
2 after BDNF stimulation. The quantification
of TrkB-FL and total proteins in fractions 2 and
6 is shown on the right. The value of densi-
tometry unit was determined for each TrkB-FL
band, and normalized to that of “ BDNF” in
fraction 2. (B) Time course of BDNF-induced
recruitment of TrkB-FL into rafts. Neurons were
treated with 200 ng/ml BDNF for the indi-
cated times. (C) Dose-dependent translocation
of TrkB-FL into rafts. Neurons were treated
with the indicated concentration of BDNF for
30 min. *Indicates significantly different
from “ BDNF” in fraction 2; t test; P  
0.05. n   6 preparations from five indepen-
dent experiments (A), 4 preparations from
three independent experiments (B), and 3
preparations from two independent experi-
ments (C). Error bars in this and all other figures
represent SEM. 
BDNF-INDUCED TRANSLOCATION OF TRKB INTO LIPID RAFTS • SUZUKI ET AL.
 
1207
 
tions. A 30-min treatment with BDNF did not change the distri-
bution of TfR, a nontyrosine kinase receptor, or EGF receptor,
a tyrosine kinase receptor (Fig. 1 A, left). Together, these data
suggest that BDNF rapidly and selectively induces the translo-
cation of TrkB-FL from nonrafts into lipid rafts.
 
TrkB translocation: dependence on its 
tyrosine kinase activity
 
Binding of BDNF to TrkB-FL induces the autophosphorylation
of its tyrosine residues on the intracellular kinase domain, lead-
ing to its activation (Kaplan and Miller, 2000). To test whether
TrkB recruited into rafts is activated, we performed Western
blot analysis using anti–phospho-Trk antibody (pY490; Binder
et al., 1999). In neurons treated with BDNF for 30 min, a sub-
stantial amount of TrkB-FL recruited into rafts was tyrosine
phosphorylated (Fig. 2 A, top). In BDNF-treated cultures,
TrkB-FL tyrosine phosphorylation relative to total TrkB-FL
protein was not significantly different between in rafts and in
nonrafts (Fig. 2 A, bottom; P 
 
 
 
 0.64). To investigate whether
activation of TrkB tyrosine kinase was required for the translo-
cation of TrkB-FL into lipid rafts, we performed the following
experiments. First, we treated cortical neurons with the Trk ki-
nase inhibitors, K252a or AG879 for 3 h before BDNF stimula-
tion (Fig. 2 B). K252a (100 nM), which reduced BDNF-depen-
dent TrkB tyrosine phosphorylation by 68.8 
 
 
 
 12.2% in rafts
and by 49.4 
 
 
 
 7.0% in the nonrafts (
 
n
 
 
 
 
 
 3 independent experi-
ments), inhibited BDNF-induced TrkB-FL translocation (Fig. 2
B). BDNF-dependent recruitment of TrkB-FL into rafts was
also blocked by another Trk kinase inhibitor AG879 (10 
 
 
 
M).
Second, because TrkB activation could be induced by a 1-min
exposure to BDNF (Takei et al., 1998), we tested whether this
short-term stimulation would allow recruitment and partition of
TrkB-FL in rafts. Cultured cortical neurons were stimulated
with BDNF for 1 min, followed by incubation with medium
containing no BDNF for 5–360 min. As shown in Fig. 2 C, a
1-min stimulation with BDNF was sufficient to recruit TrkB-FL
into rafts. The amount of TrkB-FL continued to increase after
BDNF was washed out, suggesting that once activated TrkB-
FL can move into lipid rafts. Third, TrkB-T1, a truncated form
of the TrkB receptor lacking tyrosine kinase domain, did not
appear to be partitioned into rafts by BDNF (Fig. S3A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200404106/DC1).
Finally, NT-4 (200 ng/ml, 30 min), another ligand that acti-
vates TrkB tyrosine kinase, recruited TrkB-FL into rafts (Fig.
S3 B). Together, these results suggest that BDNF-induced
translocation of TrkB into rafts requires its tyrosine kinase ac-
tivity. Because cultured astrocytes expressed TrkB-T1, but not
TrkB-FL (Fig. S3 C), the TrkB-FL translocation is likely to oc-
cur in neurons only.
 
Regulation of BDNF-induced 
translocation of TrkB into rafts by 
p75
 
NTR
 
How is BDNF-dependent translocation of TrkB-FL into rafts
regulated? Given that the pan-neurotrophin receptor, p75
 
NTR
 
associates with lipid rafts (Higuchi et al., 2003) and forms a
heterodimer with Trk family receptors (Hempstead, 2002),
p75
 
NTR
 
 may facilitate BDNF-dependent association of TrkB
with rafts. To test this, we introduced p75
 
NTR
 
 or lacZ into corti-
cal neurons using adenovirus-mediated gene transfer. In corti-
cal neurons expressing lacZ, p75
 
NTR
 
 was not detectable both in
raft fraction and nonraft fraction (Fig. 3, lacZ). Infection of cor-
tical neurons with p75
 
NTR
 
 adenovirus resulted in the expression
of the 75-kD p75
 
NTR
 
 (Fig. 3, p75). The p75
 
NTR
 
 did not interfere
with basal association of TrkB with rafts or TrkB phosphoryla-
tion outside rafts. Interestingly, the expression of exogenous
p75
 
NTR
 
 in cortical neurons markedly inhibited BDNF-depen-
dent translocation of TrkB-FL into lipid rafts (Fig. 3, TrkB-
FL
 
rafts
 
). Consequently, phosphorylated TrkB-FL was not detected
in the rafts (Fig. 3, pTrkB
 
rafts
 
). Moreover, application of BDNF
did not increase the amount of p75
 
NTR
 
 in the rafts (Fig. 3,
p75
 
rafts
 
). Together, these data suggest that a lipid raft-associated
Figure 2. Requirement of TrkB activation for BDNF-induced TrkB trans-
location into lipid rafts. Immunoblots were performed using anti-TrkB and
anti–phospho-Trk antibodies. (A) TrkB-FL recruited into rafts is tyrosine
phosphorylated. Cortical neurons were treated with (200 ng/ml) or without
BDNF for 30 min. (Top) Sample blots. (Bottom) Quantification. pTrkB-FL/
total TrkB-FL was quantified in fractions 2 and 6, and shown as relative to
that of “ BDNF” in fraction 6. n   5 preparations from five independent
experiments. (B) Inhibition of TrkB-FL activation prevents TrkB-FL translocation
into lipid rafts. Neurons were treated with 100 nM K252a or 10  M
AG879 for 3 h, followed by a 30-min stimulation with 200 ng/ml BDNF.
(C) Effect of a brief exposure to BDNF on TrkB-FL translocation. Cortical
neurons were treated with 200 ng/ml BDNF for only 1 min followed by
incubating with medium containing no BDNF for the indicated times. Note
that once activated, TrkB-FL continued to be partitioned into rafts in the
absence of BDNF. 
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pan-neurotrophin receptor p75
 
NTR
 
 has an inhibitory role in
BDNF-dependent translocation of TrkB-FL into rafts.
 
Distribution of signaling molecules 
downstream of TrkB-FL in lipid rafts and 
nonrafts
 
Phosphorylated tyrosine residues on the TrkB intracellular do-
main form docking sites for the signaling proteins Shc, Grb2,
and PLC
 
 
 
, leading to activation of MAPK (Erks), PLC
 
 
 
, and
PI3-K pathways (Kaplan and Miller, 2000). We tested
whether TrkB-FL, upon BDNF stimulation, carries these sig-
naling molecules into lipid rafts during its translocation. In
naïve neurons, Erks extended throughout the gradient (frac-
tions 2–5), whereas Shc, Grb2, p85 subunit of PI3-K, Akt, and
PLC
 
 
 
 were primarily localized in the bottom, nonraft fraction
(Fig. 4 A, left). BDNF application did not increase the amount
of any of these proteins in fraction 2 (Fig. 4 A, right), suggest-
ing that TrkB-FL does not carry its associated signaling
molecules into lipid rafts during its translocation. When a
milder detergent Triton X-165 was used to prepare rafts (Fig.
S4 A, available at http://www.jcb.org/cgi/content/full/jcb.
200404106/DC1), many of them (Shc, Grb2, Erks, and PLC
 
 
 
)
were extended throughout the gradient whereas p85 subunit of
PI3-K and Akt appeared to be still in nonraft fraction. It was
notable that BDNF did not stimulate the translocation of these
signaling molecules into rafts (Fig. S4 A). Parallel to these,
BDNF-induced translocation of TrkB-FL (Fig. 4 B, left) was
accompanied by a significant increase in the phosphorylation
of Erks (Figs. 4 B, middle and Fig. 4 D), but not that of Akt
(Fig. 4 B, right and Fig. 4 D), in lipid rafts. In nonraft regions,
however, both Erks and Akt were activated by BDNF applica-
tion (Fig. 4, C and D). Thus, although TrkB-FL does not move
with its associated proteins during translocation, the translo-
cation of TrkB-FL itself into rafts may be a key event in form-
ing TrkB signaling complex, including TrkB-FL and its asso-
ciated proteins, in rafts, leading to preferential activation of
Erks over Akt in neuronal lipid rafts.
 
Requirement of lipid rafts for short-term 
synaptic modulation by BDNF
 
What is the functional role of BDNF-induced TrkB transloca-
tion into lipid rafts? Because the translocation was observed 1
min after BDNF application (Fig. S2), we reasoned that this
process may be involved in the short-term actions of BDNF
(Lu, 2003). BDNF has been shown to rapidly enhance transmit-
ter release in cultured cortical neurons (Matsumoto et al., 2001).
Therefore, we tested whether disruption of lipid rafts would in-
terfere with BDNF modulation of depolarization-evoked trans-
mitter release at CNS synapses. Methyl-
 
 
 
-cyclodextrin (MCD)
binds and depletes cholesterol from the plasma membrane, and
thereby disrupts lipid rafts (Simons and Toomre, 2000). A 10-
min treatment with MCD (2 mM) removed membrane choles-
terol by 33 
 
 
 
 2% (91 
 
 
 
 2 ng/well in control cultures, 61.2 
 
 
 
 2
ng/well in MCD-treated cultures, 
 
n
 
 
 
 
 
 4 independent experi-
ments), but did not affect the amount of caveolin-2 and Fyn in
lipid rafts (Fig. 5 A, right). Treatment of the cultured cortical
neurons with 2 mM MCD significantly attenuated the BDNF-
induced recruitment of TrkB-FL into the rafts (Fig. 5 A, left and
middle). Consequently, the amount of phosphorylated TrkB
was also reduced in the rafts. Importantly, TrkB phosphoryla-
tion in the nonraft fraction was not affected. Thus, cholesterol
may play a role in TrkB translocation into lipid rafts.
We reported previously that in cultured cortical neurons,
pretreatment with BDNF enhanced glutamate release evoked
by 4-amino pyridine (4-AP), a K
 
 
 
 channel blocker frequently
used in biochemical assays of evoked neurotransmitter release
(Matsumoto et al., 2001). As shown in Fig. 5 B, pretreatment
with BDNF for 30 min had no effect on the content of
glutamate in the medium (white bars in BDNF-pretreated cul-
tures), but significantly enhanced 4-AP–induced glutamate re-
lease (hatched bars in BDNF-pretreated cultures). A 10-min
treatment with 2 mM MCD before BDNF exposure, however,
abolished BDNF enhancement of 4-AP–evoked glutamate re-
lease. The neurons pretreated with 2mM MCD alone displayed
4-AP–evoked glutamate release, which was comparable to that
in control neurons, indicating that cholesterol depletion itself
does not impair the exocytosis machinery. Long-term treatment
with raft depleting agents such as fumonisin B
 
1
 
 and mevastatin
has been reported to lead to instability of AMPA receptors and
loss of dendritic spines and synapses (Hering et al., 2003). In
contrast, dendritic parameters (Murphy and Segal, 1996) were
not affected by short-term treatment (30 min) with 2 mM
MCD. The dendritic diameter was about the same in control
cultures and MCD-treated cultures (1.19 
 
 
 
 0.04 
 
 
 
m in control
cells and 1.18 
 
 
 
 0.04 
 
 
 
m in MCD-treated cells, 
 
n
 
 
 
 
 
 415 seg-
ments). Likewise, MCD treatment did not change spine density
(spine number per 10 
 
 
 
m dendritic segment; 2.47 
 
 
 
 0.11 in
control cells, 2.36 
 
 
 
 0.10 in cells treated with 2 mM MCD,
 
n
 
 
 
 
 
 945). Furthermore, immunocytochemistry using antibod-
ies against the presynaptic marker synaptophysin and postsyn-
aptic marker PSD95 indicated that short-term MCD treatment
did not alter the number or the distribution of synapses (Fig. 5
C). These data support the notion that MCD selectively pre-
vents the residing of activated TrkB in lipid rafts, leading to
impairments of BDNF modulation of glutamate release.
Figure 3. Inhibition of BDNF-induced TrkB translocation by p75
NTR.
Cultured cortical neurons were infected with adenovirus expressing p75
NTR
or lacZ as described in Materials and methods. Cells were treated without
or with 200 ng/ml BDNF for 30 min. The fractions of rafts and nonrafts
were immunoblotted for the indicated proteins. (Top) BDNF-induced trans-
location and activation of TrkB-FL is inhibited by p75
NTR expression. (Bottom)
The location and activation of TrkB-FL in nonrafts are not influenced by
p75
NTR expression. BDNF did not affect the distribution of p75
NTR in rafts
and nonrafts. Similar results were obtained from two separate experiments. 
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The biochemical assay described above measures
both synaptic and nonsynaptic glutamate release. To determine
whether lipid rafts are important for BDNF modulation of neu-
rotransmitter release at synapses, we measured synaptic exocy-
tosis in cultured hippocampal neurons using a style membrane
dye FM1-43 (Ryan et al., 1993). A second depolarization of
these FM dye-loaded neurons by high K
 
 
 
 solution (see Materi-
als and methods) resulted in a rapid destaining of the FM dye-
labeled spots, reflecting transmitter release at the synapses
(Fig. 6, A and B). Pre-treatment with BDNF for 30 min en-
hanced depolarization-induced FM1-43 destaining (Fig. 6 B).
A 10-min treatment with MCD (2 mM) before BDNF applica-
tion prevented the enhancement effect of BDNF (Fig. 6 C). The
neurons pretreated with MCD alone exhibited FM1-43 destain-
ing similar to that in control neurons (Fig. 6 C), indicating that
neither uptake nor destaining of FM 1-43 dye was affected by
MCD pretreatment.
Similar to the effect of BDNF in hippocampal cultures,
BDNF enhanced depolarization-induced FM dye destaining,
and MCD attenuated the BDNF effect, in cultured cortical neu-
rons (Fig. 6 D). Several experiments were performed to ensure
that the MCD effect was due specifically to removal of choles-
terol and disruption of lipid rafts, rather than to a nonselective,
pharmacological effect such as removal of proteins from the
plasma membrane. First, we pretreated the cultures with 50 ng/
ml filipin, a cholesterol sequestration agent with a structure dis-
tinct from that of MCD (Simons and Toomre, 2000; Ma et al.,
2003). We found that, although FM 1-43 uptake appeared to be
Figure 4. Differential activation of Erks and
Ark in lipid rafts upon BDNF-induced TrkB-FL
translocation. Cultured cortical neurons were
treated with or without BDNF (200 ng/ml) for
30 min. (A) Western blot analysis of the distribu-
tion of major signaling molecules downstream
of TrkB before and after BDNF stimulation.
Similar results were obtained from two separate
experiments. (B and C) Differential activation
of Erks and Akt in lipid rafts and nonrafts after
a 30-min treatment with BDNF. Fractions 2
and 6 were immunoblotted. (D) Quantitative
analysis of BDNF effect on the activation of
Erks and Akt in rafts and nonrafts. For each
protein, phosphorylation relative to total
amount was quantified in fractions 2 and 6,
and shown as relative to that of “ BDNF” in
fraction 6. *Indicates significantly different
from “ BDNF”; t test; P   0.05. n   4 inde-
pendent experiments. In A–C, immunoblots
were performed using antibodies specific for
indicated proteins and phospho-proteins. 
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slightly lower, filipin, like MCD, completely reversed the ef-
fect of BDNF on depolarization-induced FM dye destaining
(Fig. 6 E). Neurons pretreated with filipin alone exhibited FM
dye destaining similar to that in control neurons (Fig. 6 E). Sec-
ond, if the MCD effect were due to a nonspecific removal
of membrane protein, addition of MCD–cholesterol complex
should not rescue the deficits induced by MCD. We treated the
cultures with MCD–cholesterol complex (1 mg/ml MCD bal-
anced with 40 
 
 
 
g/ml cholesterol) for 10 min (Thiele et al.,
2000). Remarkably, this treatment did not affect the potentiat-
ing effect of BDNF on depolarization-induced destaining of
FM 1-43 (Fig. 6 D). We therefore conclude that lipid rafts are
important for the modulation of neurotransmitter release and
synaptic exocytosis by BDNF.
One of the major functions of BDNF in the intact hippo-
campal synaptic circuits is to attenuate synaptic fatigue in-
duced by a train of high frequency stimulation (HFS; or teta-
nus, 100 Hz, 1 s; Figurov et al., 1996). We next examined the
role of lipid rafts in this form of synaptic modulation. In neona-
tal hippocampal slices (P12-13) in which the level of endoge-
nous BDNF is low, application of tetanus resulted in pro-
nounced synaptic fatigue at Schaffer collateral-CA1 synapses
(Fig. 7 A). Consistent with our previous reports (Figurov et al.,
1996), treatment with exogenous BDNF (2 nM) for 1–2 h sig-
nificantly attenuated the synaptic fatigue (Fig. 7 B). However,
pretreatment with MCD for 30 min completely abolished the
attenuating effect of BDNF on HFS-induced synaptic fatigue.
Quantitative analysis indicated that treatment with BDNF
markedly increased the rate constant (
 
 
 
) for synaptic fatigue
and disruption of lipid rafts with MCD completely prevented
such an increase (Fig. 7 C). It is important to note that treat-
ment with MCD for 3 h had no effect on synaptic responses to
HFS (Fig. 7, B and C), nor did MCD affect basal synaptic
transmission or tetanus induced LTP (Ma et al., 2003). These
results suggest that short-term exposure to MCD per se does
not affect the number of readily releasable vesicles in the pre-
synaptic terminals or the number or properties of AMPA or
NMDA receptors on the postsynaptic density.
 
Requirement of lipid rafts for long-term 
regulation of dendritic growth, but not 
neuronal survival, by BDNF
 
To test whether lipid rafts are also involved in long-term ef-
fects of BDNF, we treated cultures with cholesterol synthesis
inhibitors, mevastatin or pravastatin, which effectively deplete
rafts from cortical neurons over days (Hering et al., 2003). The
cholesterol level was significantly reduced in mevastatin- or
pravastatin-treated cortical neurons (Fig. 8 A). We first exam-
Figure 5. Inhibition of BDNF-induced TrkB-FL translocation and evoked glutamate release by lipid raft disruption. (A) Effect of MCD on BDNF-induced TrkB
translocation. Cortical neurons were treated with or without MCD (2 mM) for 10 min. (Left) Raft (fraction 2) and nonraft fractions (fraction 6) were immuno-
blotted for the indicated proteins. Note that MCD blocked BDNF-induced TrkB phosphorylation in rafts and translocation to rafts. (Middle) TrkB-FLfraction 2/
TrkB-FLfraction 6 was quantified and shown as relative to “ BDNF” in control cultures (n   4 preparations from three independent experiments). *Indicates
significantly different from “ BDNF” in control cultures; t test; P   0.01. (Right) Treatment with 2 mM MCD for 10 min did not influence the amount of
caveolin-2 and Fyn in lipid raft fraction. (B) Effect of MCD on BDNF enhancement of 4-AP–evoked glutamate release from cortical neurons. Neurons were
pretreated with or without 2 mM MCD for 10 min, followed by incubation with or without BDNF for 30 min. After washing four times, neurons were stimulated
with 1 mM 4-AP. *Indicates significantly higher than all other 4-AP–treated groups; ANOVA test; P   0.05; n   4 cultures. There was no statistically significant
difference among all white bars (ANOVA test, P   0.48). Similar results were obtained from three independent experiments. (C) Effect of short-term treatment
with MCD on the number and distribution of synapses. (Left) Immunocytochemistry for the indicated proteins was done after a 30-min incubation with or
without 2 mM MCD. (Right) The number of synapses (doubly labeled by anti–PSD-95 and anti-synaptophysin antibodies) was determined and shown as
relative to that of “Control” (n   90 dendritic segments with 50- m length from three independent coverslips and experiments). Note that there is no significant
difference in distribution and number of the immunopositive synapses between control and MCD-treated cultures. Bar, 5  m.BDNF-INDUCED TRANSLOCATION OF TRKB INTO LIPID RAFTS • SUZUKI ET AL. 1211
ined the effect of these lipid raft disrupters on BDNF regulation
of neuronal survival, using the WST-1 assay, which quantita-
tively determines cell viability based on the cleavage activity
of a soluble tetrazolium salt WST-1 by mitochondrial dehydro-
genases, and by counting the number of MAP2-positive neu-
rons in culture. 3-d treatment with BDNF significantly en-
hanced the survival of cortical neurons in serum-free medium
(Fig. 8, B and C, left; Yamada et al., 2001). Both mevastatin
and pravastatin, however, failed to block this effect of BDNF
(Fig. 8, B and C, middle and right), indicating that lipid rafts
are not required for the regulatory effect of BDNF on cortical
neuron survival.
BDNF has also been shown to be a potential regulator for
dendritic growth of CNS neurons (McAllister et al., 1995). We
next examined whether lipid rafts are important for BDNF regu-
lation of dendritic growth. 3-d exposure of BDNF led to robust
growth of MAP2-positive primary dendrites (Fig. 8 D, BDNF).
Quantitative analysis revealed that BDNF increased the number
of primary dendrites by  50% (P   0.001). This effect of BDNF,
however, was effectively blocked by mevastatin, whereas treat-
ment with mevastatin alone had no effect (Fig. 8 D). Thus, while
required for short-term modulation of synaptic transmission and
plasticity by BDNF, lipid rafts may mediate some, but not all
long-term effects of BDNF in CNS neurons.
Discussion
One of the conceptually difficult issues in neurotrophin re-
search is how a single neurotrophin could elicit different ef-
fects under different conditions on the same neurons, or on cer-
tain parts of the same neurons (Bibel and Barde, 2000). How
could, for example, BDNF regulate synaptic transmission with-
out altering the survival of neurons of adult cortex? One way to
ensure signaling specificity is to induce BDNF signaling in
specific subcellular compartments. In the present study, we
demonstrated that BDNF stimulation induced the translocation
of activated TrkB-FL from nonrafts to lipid rafts in cortical
neurons. We further showed that attenuation of such transloca-
tion by depleting cholesterol in the lipid rafts prevented the ef-
fects of BDNF on synaptic transmission and plasticity, but not
neuronal survival. These results reveal a new mechanism for
the signaling specificity of BDNF, and suggest a critical role of
lipid rafts in the synaptic function of BDNF in CNS neurons.
BDNF-induced translocation of activated 
TrkB into lipid rafts
One of the key findings in the present study is that TrkB translo-
cation to rafts depends on its tyrosine kinase activity. This notion
is supported by a number of observations: (a) inhibition of the
Trk kinase activity by K252a or AG879 significantly inhibited
BDNF-induced translocation of TrkB-FL; (b) NT-4, which acti-
vates the TrkB RTK, also induced TrkB-FL translocation; (c)
1-min exposure of BDNF, which activates TrkB, was sufficient
to partition TrkB-FL into rafts. Thus, TrkB activation has to oc-
cur before the translocation; and (d) TrkB-T1, the truncated form
of TrkB lacking the tyrosine kinase domain, was not recruited
into rafts by BDNF. This last result, however, has to be inter-
preted with caution. It is also possible that the intracellular do-
main of the TrkB receptor may contain motifs that interact with
other proteins important for the delivery of TrkB to the lipid rafts.
Another important observation is that removing of cho-
lesterol, a major component in the lipid rafts, with 2 mM MCD
inhibited TrkB signaling, leading to impairments in synaptic
transmission and plasticity. The most straightforward interpre-
tation is that MCD disrupted BDNF-induced translocation of
TrkB-FL into rafts, and consequently impaired TrkB signaling
Figure 6. Attenuation of BDNF enhancement of synaptic
exocytosis by lipid raft disruption. Recycling synaptic
vesicles in cultured hippocampal or cortical neurons
were labeled by FM1-43, and exocytosis was induced
by a perfusion of 50 mM KCl containing KRH buffer (high
K
  solution). (A) Pseudo-colored images showing high
K
  solution-dependent reduction in FM1-43 intensity. FM
1-43 images were captured at the indicated times (s) and
baseline intensity was captured at 5 s before depolar-
ization. The monochromic image shows the neuron 5 min
before stimulation. Arrowheads indicate representative
spots with a gradual reduction of FM dye labeling after
depolarization. Bar, 10  m. (B) Representative recordings
of FM 1-43 destaining. Neurons were incubated with or
without BDNF for 30 min, followed by a 1-min exposure
to high K
  solution to load FM dye. After three washes for
5 min, FM dye was destained with high K
  solution (black
arrow). FM 1-43 intensities at 4 s before (gray arrow) and
at 15 s after (white arrow) depolarization are defined as
Fb and Fa, respectively.  F (%)   (Fb Fa)/Fb   100. (C–E)
Summary of FM dye destaining experiments using hippo-
campal neurons (C) and cortical neurons (D and E). Cells
were pretreated with MCD, MCD–cholesterol complex
(MCD-Chol), or filipin for 10 min, followed by BDNF
incubation for 30 min and stimulation with high K
  solution.
Data were collected at 4 s before and at 15 s after stimu-
lation with high K
  solution. The number associated with
each column represents the number of spots recorded for each condition. A 1-min incubation with 5 mM KCl did not elicit any significant change in the
intensity of FM 1-43 (not depicted). In all experiments similar results were obtained from at least two independent experiments.JCB • VOLUME 167 • NUMBER 6 • 2004 1212
in rafts. Alternatively, TrkB may need to interact with choles-
terol to become fully functional, and therefore depletion of
cholesterol directly affects TrkB signaling, rather than TrkB
translocation. Consistent with this idea, BDNF failed to induce
TrkB phosphorylation on the cell surface in cultured striatal
neurons from Niemann-Pick type C mice (NPC / ), which
have abnormal cholesterol metabolism (Henderson et al.,
2000). The fact that there was a small amount of TrkB in lipid
rafts in naïve cells (Fig. 1 A) also supports the idea that TrkB
interacts with rafts, perhaps with a low affinity. However, sev-
eral observations argue against this idea. First, in cultured stri-
atal neurons from NPC / , the content of free cholesterol was
normal, suggesting that the cholesterol-rich microdomains on
cell surface are probably normal. Thus, the dysfunction of
TrkB on cell surface in NPC /  is probably due to reasons
other than lack of cholesterol in the plasma membrane. Second,
we demonstrated that treatment with 2 mM MCD, which re-
moved membrane cholesterol by 33%, interfered with TrkB re-
cruitment into rafts, but not TrkB activation outside rafts (Fig.
5 A). The basal level of TrkB localization in rafts in resting
cells was normal as well. Finally, treatment with 10 mM MCD,
which removed  95% cholesterol, did not diminish TrkB ki-
nase activity (Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200404106/DC1). These data suggest that cho-
lesterol is involved in the recruitment of TrkB into lipid rafts,
but not directly in TrkB function.
A third possible mechanism for TrkB translocation is
that BDNF signaling involves an interaction between TrkB
and protein X, which could be a protein embedded in choles-
terol-rich membranes. Cholesterol depletion could in princi-
ple lead to structural changes in the protein X (Simons and
Toomre, 2000; Munro, 2003; Glebov and Nichols, 2004), and
therefore disturb its interaction with TrkB. Although the
nature of protein X remains unknown, we tested whether
p75
NTR, which is primarily associates with rafts (Higuchi
et al., 2003) and is capable of binding to Trk receptors
(Hempstead, 2002), facilitates BDNF-dependent transloca-
tion of TrkB into rafts. Interestingly, expression of exogenous
p75
NTR in cortical neurons inhibited TrkB translocation into
lipid rafts, as well as the level of TrkB phosphorylation in the
rafts, but not the basal association of TrkB with rafts or TrkB
phosphorylation outside rafts (Fig. 3). These data are opposite
to the above prediction and suggest that p75
NTR has an inhibi-
tory function in TrkB translocation and lipid raft-mediated
BDNF/TrkB signaling. Thus, although it is unlikely that
BDNF-induced TrkB translocation into lipid rafts is mediated
by p75
NTR through its interaction with TrkB, our experiments
could not rule out the possibility that a protein X is an inter-
mediate for BDNF-induced TrkB translocation into rafts.
The dynamic behavior of TrkB into lipid rafts is most
analogous to that of two tyrosine kinase receptors, c-Ret for
glial cell line–derived neurotrophic factor (GDNF; Tansey et
al., 2000; Paratcha et al., 2001) and ErbB4 for neuregulin (Ma
et al., 2003). c-Ret is recruited into lipid rafts upon GDNF
stimulation by two distinct mechanisms. In cells expressing
c-Ret and GPI-anchored protein GFR 1 (GDNF family receptor
 1), which is primarily associated with lipid rafts, the binding
of GDNF to GFR 1 results in a transient recruitment of c-Ret
into the compartment. Unlike TrkB translocation, this move-
ment is independent of the kinase activity. In cells lacking
GPI-anchored GFR 1, however, coapplication of GDNF and
soluble GFR 1 allows stabilization of c-Ret in rafts, and this
effect is tyrosine kinase-activity dependent. These mecha-
nisms lead to the association of c-Ret with different adaptor
Figure 7. Effect of MCD on BDNF modulation of synaptic fatigue at hippo-
campal CA1 synapses. Neonatal hippocampal slices were pretreated with
MCD (2 mM) for 30 min before treatment with BDNF (2 nM) for 1–2 h. A
train of HFS (100 Hz, 1 s) was applied to Shaffer collaterals and field EPSPs
were recorded from stratum radiatum. The slopes of EPSPs during the entire
recording were normalized to the first EPSP slope in each recording. (A) An
example of EPSPs elicited by HFS recorded from a BDNF-treated slice. (B)
Effect of MCD on synaptic depression induced by HFS. Normalized EPSP
slopes in each condition were averaged and plotted against the number of
stimulus during HFS. (C) Summary of the MCD effect on the rate of synaptic
depression. The plot for each recording was fitted with a single exponential
curve, and rate constant ( ) for each condition was averaged and pre-
sented. *Indicates significantly higher than all other groups; ANOVA
followed by post hoc tests; P   0.001. The number associated with each
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proteins inside rafts and elicit neuronal survival and differenti-
ation. Similar to TrkB-FL, ErbB4 is recruited into lipid rafts
by neuregulin. However, it is unclear whether ErbB4 translo-
cation depends on its kinase activity. Although neuregulin
translocates the whole receptor complex, including ErbB4 and
its adaptor proteins, such as Grb2 and Shc, into rafts, BDNF
recruited TrkB alone into lipid rafts, without carrying its asso-
ciated proteins Shc, Grb2, and PLC  (Fig. 4 A and Fig. S4 A).
However, we cannot completely rule out the possibility that
the movement of these associated proteins into rafts was under
the detection limit of our immunoblotting analysis. Given that
Shc, Grb2, Erks, and PLC  were present in lipid rafts in an ex-
periment using a milder detergent Triton X-165 (Fig. S4 A), it
is possible that the movement of TrkB-FL into rafts allows
TrkB to interact with signaling molecules inside the rafts, a
step crucial in transmitting lipid raft-mediated BDNF/TrkB
signal transduction.
The raft localization of detergent insoluble proteins in-
cluding RTKs depends on cell type and detergent stringency
(Pike, 2003; Schuck et al., 2003). For example, when a less
stringent detergent (Triton X-165) was used, a larger amount
of TrkB-FL was associated with rafts in naïve cells, and
BDNF-induced movement of TrkB-FL from nonrafts to rafts
became less apparent (Fig. S4 B). In PC12 cells, both TrkA
and p75
NTR are constitutively localized in caveolae/lipid rafts
(Bilderback et al., 1999; Huang et al., 1999) and NGF binding
does not alter the partition of TrkA and p75
NTR in lipid rafts
(Huang et al., 1999). This may be due to the specific cell
types they are expressed or their association with lipid raft-
anchored proteins.
Role of BDNF-dependent TrkB 
translocation into lipid raft in synaptic 
modulation
The present study has revealed the importance of TrkB translo-
cation into rafts in short-term modulation of synaptic transmis-
sion and plasticity by BDNF. In contrast, lipid rafts are not re-
quired for BDNF regulation of cortical neuron survival. In
neurons, lipid rafts are preferentially distributed in synaptic
membranes (Ma et al., 2003). In cerebral cortex in vivo, TrkB-
FL is present in lipid rafts (Fig. S1 B). Moreover, the endoge-
nous BDNF appears to be enriched in lipid raft fractions in the
adult cortex (Fig. S1 B), stored in vesicles in synaptosomes
(Fawcett et al., 1997), and secreted at synapses in an activity-
dependent manner (Hartmann et al., 2001; Kojima et al., 2001).
Thus, the translocation of TrkB into lipid rafts may imply a
BDNF-induced recruitment of TrkB into the synapses.
Because BDNF elicits the synaptic effects through
presynaptic mechanisms (Gottschalk et al., 1998; Lessmann,
1998), activated TrkB may need to be translocated to the rafts
in the presynaptic terminals to interact with its target mole-
cules. The specific target molecules mediating the presynaptic
effects of BDNF, however, remain to be fully identified. In pu-
rified nerve terminals (synaptosomes) from cerebral cortices,
application of BDNF facilitates evoked glutamate release and
increases the MAPK-dependent phosphorylation of synapsin I,
a synaptic vesicle-associated protein implicated in the control
of transmitter release (Jovanovic et al., 2000), suggesting a crit-
ical role in the TrkB/MAPK/synapsin signaling cascade. BDNF
also rapidly induces MAPK phosphorylation in these slices and
inhibition of MAPK signaling blocks BDNF modulation of
Figure 8. Effects of raft depletion on BDNF
regulation of dendritic growth and cell survival.
Cultured cortical neurons were treated with or
without 10  M mevastatin (Meva) or 10  M
pravastatin (Prava) in the absence or presence
of 200 ng/ml BDNF. Membrane cholesterol
content, cell survival, or the number of primary
dendrites was measured 3 d later. (A) Effect of
mevastatin or pravastatin on membrane cho-
lesterol levels. The data are expressed as the
percentage of control (nontreated cultures).
*Indicates significantly lower than control;
P   0.001 (t test). n   5 cultures in each group.
(B) Effect of mevastatin or pravastatin on cell
viability. Viability of cortical neurons was
measured by the WST-1 colorimetric assay,
and expressed as OD450. t test; *P   0.05,
**P   0.01. (C) Effect of mevastatin or prava-
statin on the number of MAP-positive neurons.
Data are expressed as the percentage of control
(nontreated cultures). *P   0.01, **P  
0.05. In both B and C, the number associated
with each column represents the number of
cultures used in a single experiment, and three
independent experiments were performed. No
difference was found between the “ BDNF”
groups, nor between the “ BDNF” groups
(ANOVA test). (D) The effect of mevastatin on
BDNF modulation of dendritic growth. (Left)
Representative images of MAP2-stained neurons.
After 3-d incubation with BDNF and/or Meva, cells were stained with anti-MAP2 antibody. Note that the number of primary dendrites (arrowheads) is
increased by BDNF treatment, and that the effect is completely blocked by mevastatin. Bar, 10  m. (Right) The number of primary dendrites was quantified
and normalized to that of the control. *Indicates significantly higher than all other groups; ANOVA followed by post hoc test; P   0.00002. The number
associated with each column indicates the number of neurons measured in a single experiment, and three independent experiments were performed.JCB • VOLUME 167 • NUMBER 6 • 2004 1214
HFS response (Gottschalk et al., 1999). In the present study,
when TrkB was translocated into lipid rafts, Erks appeared to
be activated in the rafts (Fig. 4 B). Assuming that TrkB-FL is
rapidly translocated into the rafts in synaptic membranes, acti-
vation of Erks in rafts may lead to the phosphorylation of pre-
synaptic molecules (e.g., synapsin, synaptobrevin, or synapto-
physin) necessary to mediate BDNF effects at CNS synapses.
Materials and methods
Primary cultures
Dissociated cultures of cortical and hippocampal neurons were prepared
from embryonic day 20 and cultured. The details were described in On-
line supplemental material.
Preparation of lipid rafts and Western blot analysis
Lipid rafts were prepared according to the method of Kawabuchi et al.
(2000). Cultured neurons (3.5  10
5 cells/cm
2) were rinsed with PBS and
quickly lysed in 0.5 ml ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, 1
mM EDTA, 0.15 M NaCl, 10 mM NaF, 1 mM Na3VO4, 1% Triton X-100,
1 mM PMSF, 10 mM Na2P2O7, 100  M phenylarsine oxide) and incu-
bated at 4 C for 30 min. For a separate experiment (Fig. S4), 1% Triton
X-165 was used. The lysates were mixed with an equal volume of 100%
(wt/vol) sucrose in buffer A (50 mM Tris-HCl, pH 7.4, 5 mM NaCl, 1 mM
Na3VO4, 1 mM PMSF, 100  M phenylarsine oxide). The mixture was
transferred to a centrifuge tube, and 8 ml of 35% (wt/vol) sucrose in
buffer A and 3.5 ml of 5% (wt/vol) sucrose in buffer A were overlaid se-
quentially. After centrifugation at 2   10
5 g for 13 h at 4 C, six fractions
were collected from the top of the gradient (the first fraction, 2.5 ml; other
fractions, 2.0 ml). To measure cholesterol, 50  l of each fraction was ana-
lyzed with the cholesterol assay kit (Wako). To isolate lipid rafts from cor-
tex, rats of different ages were decapitated and cortexes were removed
quickly. This procedure was strictly in accord with the protocols approved
by the Institutional Animal Care and Use Committee of AIST. Western blot
analysis was performed as described previously (Guirland et al., 2004).
To determine the concentration of protein, we used BCA protein assay kit
(Pierce Chemical Co.).
Recombinant adenovirus
The rat p75
NTR cDNA was supplied by E. Shooter (Stanford University, Stan-
ford, CA). The adenovirus vector pAxCAwt was kindly provided by I. Saito
(University of Tokyo, Tokyo, Japan). For adenovirus generation, see Online
supplemental material. The recombinant adenovirus was used at a multiplic-
ity of infection of 5. After 6 d in culture, cells were infected with adenovirus
for 24 h followed by a 24-h incubation in serum-free DME to assay.
Glutamate release
For this assay, cultured neurons (6  10
5 cells/cm
2) were prepared as de-
scribed previously (Matsumoto et al., 2001). After 5 h incubation in se-
rum-free medium, the neurons were washed four times with Krebs’-
Ringer’s-Henseleit (KRH) buffer containing 130 mM NaCl, 5 mM KCl, 1.2
mM NaH2PO4, 1.8 mM CaCl2, 10 mM glucose, and 25 mM Hepes, pH
7.4, and pretreated with or without MCD for 10 min followed by BDNF in-
cubation for 30 min. To induce glutamate release, 1 mM 4-AP was ap-
plied (Matsumoto et al., 2001). The glutamate released was measured us-
ing Amplex red glutamic acid oxidase kit (Molecular Probes).
Exocytosis assay using FM dye destaining
Dissociated neurons (5  10
4 cells/cm
2) were cultured on polyethylen-
imine-coated glasses (Matsunami; Numakawa et al., 2002). After wash-
ing three times with KRH buffer, neurons were pretreated with or without
MCD, MCD–cholesterol complex or filipin for 10 min followed by BDNF
incubation for 30 min. FM dye (2 mM; Molecular Probes) was loaded by
incubating the cells with the high K
  solution (KRH buffer containing 56
mM KCl and 79 mM NaCl) for 1 min at 37 C. After washing the cells with
KRH buffer, fluorescence images of FM-labeled spots were taken every
second using fluorescence microscope (model IX70; Olympus) equipped
with a Cool SNAP HQ CCD camera (Roper Scientific) and a 20   0.8
NA objective (Olympus). The baseline intensity was at 4 s before the
stimulation with high K
  solution. To induce FM dye destaining, neurons
were depolarized with high K
  solution. FM-labeled spots/50- m dendrite
were analyzed using a quantification menu of the MetaMorph software
(Universal Imaging Co.).
Slice preparation and electrophysiology
Recording of hippocampal slices, prepared from neonatal rat (P12-13),
was described previously (Figurov et al., 1996). Field EPSPs were evoked
in CA1 stratum radiatum by stimulating Schaeffer-commissurals and were
recorded with ACSF-filled glass pipettes ( 5 M ). Only slices exhibiting
EPSPs of 2–3mV in amplitude without superimposed population spikes
were used. Stimulus intensity was adjusted to evoked EPSPs of  1.3 mV.
A train of HFS (100 Hz, 1 s) was used to induce synaptic depression. All
experimental data were collected at least 10 min after stable EPSPs were
achieved. Slices were treated with MCD (2 mM) or BDNF (2 nM) or them
together for 2 h before synaptic responses to HFS were tested.
Assays of cell survival and dendritic growth
Cortical neurons (5  10
4 cells/cm
2) were cultured in Neurobasal medium
containing B27 supplement (GIBCO BRL), 0.5 mM glutamine, for 3 d, and
treated with indicated agents in Neurobasal medium containing no B27
supplement for 3 d. Cell survival was quantitated by WST-1 assay, which
determines cell viability based on the cleavage activity of a soluble tetra-
zolium salt WST-1 by mitochondrial dehydrogenases. In brief, cultured
cortical neurons were incubated with a tetrazolium salt WST-1 (Roche) for
30 min and viable cells were then determined by a microplate reader at
450 nm with 650 nm as a reference wavelength. Alternatively, the num-
ber of MAP2-positive neurons was counted (Yamada et al., 2001). To
identify primary dendrites from each neuron, cells were stained with anti-
MAP2 antibody, followed by DAPI staining. After taking images of MAP2-
positive neurons with cell body of diameter (16.9   0.5  m diam, n   32
cells from four independent coverslips), the number of the primary den-
drites was counted.
Online supplemental material
Fig. S1 shows localization of TrkB and BDNF in lipid rafts during cortical
development. Fig. S2 shows association of TrkB-FL with lipid rafts 1 min af-
ter BDNF stimulation. Fig. S3 shows TrkB-T1 expression in rafts and non-
rafts and NT-4–induced recruitment of TrkB-FL into lipid rafts. Fig. S4
shows association of signaling molecules and TrkB with lipid rafts. Fig. S5
shows that treatment with 10 mM MCD lead to a partial decrease in
BDNF-induced activation of TrkB-FL. Further comments on the data re-
ported can be found in the legends. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200404106/DC1.
We thank Dr. Masato Okada for advice on lipid raft preparation, Drs. James
Q. Zheng and Eero Castren for helpful discussion, and Sumitomo Pharmaceu-
ticals for providing recombinant BDNF.
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